Samlyn Capital, LLC
- SEC CIK
- 0001421097
- Latest filing
- Aug 14, 2026
INZY holding history
Inozyme Pharma, Inc. in every 13F filed by Samlyn Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INZY overviewAll 13F holders of INZYFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −3,259,158−100.0% | Sold out | Holders |
| Q3 2024 | 3,259,158 | $17.0M | 0.3% | −91,377−2.7% | Reduced | Holders |
| Q2 2024 | 3,350,535 | $14.9M | 0.3% | +437,622+15.0% | Added | Holders |
| Q1 2024 | 2,912,913 | $22.3M | 0.4% | −459,645−13.6% | Reduced | Holders |
| Q4 2023 | 3,372,558 | $14.4M | 0.3% | +127,350+3.9% | Added | Holders |
| Q3 2023 | 3,245,208 | $13.6M | 0.2% | +3,245,208 | New | Holders |